Early versus deferred treatment for early stage multiple myeloma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Early Versus Deferred Treatment for Early Stage Multiple Myeloma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435022/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma.
Early versus deferred treatment for early stage multiple myeloma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435022/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma. Accessed February 13, 2025.
Early versus deferred treatment for early stage multiple myeloma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435022/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma
Early Versus Deferred Treatment for Early Stage Multiple Myeloma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435022/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Early versus deferred treatment for early stage multiple myeloma
ID - 435022
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435022/all/Early_versus_deferred_treatment_for_early_stage_multiple_myeloma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -